Although breast cancer is the second leading cause of cancer deaths among American women, mammography screening is still an undeserving target of misguided criticism […]
Multiparametric magnetic resonance imaging (MRI) and MRI-guided prostate biopsy are emerging as useful applications in the detection of prostate cancer. Transrectal ultrasound (TRUS) biopsy, the current traditional method of diagnosis prostate cancer, can result in sampling errors that lead to delayed diagnosis or misclassification of cancers. In a first-of-its-kind trial, TRUS biopsy and MRI-guided prostate biopsy were compared to see which can best detect prostate cancers and help to triage prostate cancer patients.
MRI-guided prostate biopsy outperforms TRUS biopsy
Lung cancer, the leading cause of cancer death among American men and women, will kill more than 159,000 people in 2014, according to American Cancer Society estimates. The National Lung Screening Trial (NLST) showed that, among current and former smokers, annual screening for lung cancer with low-dose computed tomography (CT) could help to reduce mortality from lung cancer by up to 20 percent. However, some patients receiving low-dose CT screening for lung cancer could be subjected to false-positive and significant incidental findings. […]
Recent research shows that new MRI-TRUS fusion biopsy can more effectively detect high-grade prostate cancers than conventional TRUS biopsy. […]
Dr. Robert Princenthal will discuss benefits of and developments in MRI prostate imaging at annual conference hosted by the Prostate Cancer Research Institute. […]